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1. Introduction
Disabled persons live in every corner of the world and on all social levels. According to UN
estimations, disabilities are much more widespread than is believed: at least one in every 10
inhabitants of each country has a certain form of disability, totaling some 450 million people
around the world. [1] According to the 2001 census, Croatia had at that time 423 891 persons
with disabilities (10% of overall population) [2]. According to the Croatian Disabilities Reg‐
istry (the Registry), [3], Croatia has 518 081 disabled persons (ca. 12% of overall population).
As defined in the Act on the Croatian Disabilities Registry, disability is a limitation or reduc‐
tion (resulting from damaged health) the capacity to perform a certain physical activity or
psychological function normal for a person of a certain age, and refers to the abilities which
are manifested in complex activities and behaviors generally accepted as important compo‐
nents of everyday life [4]. Croatia has defined the collection of data on disabled persons in
the Act on the Croatian Disabilities Registry (Official Gazette No. 64/01). The Registry in‐
cludes data on the following types of physical and mental impairments: visual, hearing and
speech impairments, impairments of the locomotor, central and peripheral nervous systems,
other organs and organ systems, mental retardation, PDDs (autism), mental disorders, as
well as data on multiple impairments. PDDs (autism) have been separated as a special disa‐
bility category. The data on the above disorders is provided by expert evaluation bodies
within the education and social welfare system [4]. According to the references, PDD preva‐
lence has registered a continual rise. To illustrate, according to the CDC Report from Atlan‐
ta, USA, prevalence numbers 6.6 per 1000. [5, 6, 7, 8, 9]. The data on individuals with PDDs
in Croatia is registered in the above Registry. However, due to a short history (since 2002),
the extent of the potential increase could not be determined.
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2. Epidemiology of PDDs globally
2.1. Classification systems
For the purpose of  learning more about the epidemiology of  autism, and,  by extension,
about the changes in its prevalence, the following part will present two classification sys‐
tems that have been in international use for many years, together with clearly stated crite‐
ria  and  diagnostic  instructions  that  need  to  be  abided  by  so  as  to  correctly  diagnose
autism and PDDs. The two systems are: WHO’s ICD-10 (International Statistical Classifica‐
tion of  Diseases and Related Health Problems)  and DSM (Diagnostic and Statistical  Manual of
Mental  Disorders)  by the American Psychiatric Association (APA).  ICD-10 defines autism
under  a  three-sign  category  of  F84:  Pervasive  developmental  disorders.  This  group  in‐
cludes, codes and defines the following: childhood autism (F84.0), atypical autism (F84.1),
Rett’s syndrome (F84.2), other childhood disintegrative disorder (F84.3), overactive disor‐
der  associated  with  mental  retardation  and  stereotyped  movements  (F84.4),  Asperger’s
syndrome (F84.5),  other  pervasive developmental  disorders (F84.8),  as  well  as  pervasive
developmental disorder, unspecified (F84.9) [10]. PDD is also defined by the APA’s DSM
classification. DSM introduced the term of pervasive developmental disorder for the first
time in its third revision from 1980. The term pervasive was selected so as to accentuate
the fact that this psychopathological manifestation assumes all of child’s spheres of func‐
tioning. In DSM Revision III  from 1987 PDDs encompass a significantly wider spectrum
of symptoms, which has lead to an increased prevalence. The term infantile autism was
changed to autistic disorder. All non-autistic pervasive disorders are specially categorized
as pervasive developmental disorders not otherwise specified (PDDNOS). Out of a need
to maximize the quality of diagnostics and create clearer diagnostic criteria DSM-III  has
grown into DSM-IV (DSM-IV-TR, APA, 2000).  The latter  classification calls  for an intro‐
duction of a new term: autism spectrum disorders (ASDs), which now defines autism [11,
12].  ASDs  ultimately  include:  autistic  disorder  (AD),  Asperger’s  syndrome  (AS)  and
PDDNOS. An approximation of the two above classification systems is visible in a series
of elements. What is significant is that both currently acknowledge a separate category of
pervasive developmental  disorders,  though the two selections of  clinical  entities  encom‐
passed by this category remain diverse. Table 1 outlays nosological categories belonging
to PDDs in the ICD-10 and DSM-IV-TR. By analyzing Table 1 a similarity can be noticed
between  the  above  classification  systems  in  determining  clinical  entities  belonging  to
PDDs. Solely hyperkinetic  disorder related to mental  retardation and stereotyped move‐
ments is left out of the DSM-IV-TR [13]. The American Psychiatric Association (APA) has
proposed  new  diagnostic  criteria  for  the  fifth  edition  of  the  Diagnostic  and  Statistical
Manual  of  Mental  Disorders  (DSM-5)  for  autism.  While  final  decisions  are  still  months
away, the recommendations reflect the work of dozens of the nation’s top scientific and
research minds and are supported by more than a decade of intensive study and analysis.
The proposal by the DSM-5 Neurodevelopmental Work Group recommends a new cate‐
gory called autism spectrum disorder which would incorporate several  previously sepa‐
rate  diagnoses,  including autistic  disorder,  Asperger’s  disorder,  childhood disintegrative
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disorder and pervasive developmental  disorder not otherwise specified [14].  Croatia ap‐
plies ICD-10 codes for PDD diagnoses.
ICD-10 (WHO, 1992) DSM-IV-TR (APA, 2000)
F 84.0 Childhood autism 299.00 Autistic disorder
F84.1 Atypical autism PDDNOS
F 84.2 Rett's syndrome 299.80 Rett’s disorder
F84.3 Other childhood disintegrative disorders 299.10 Childhood disintegrative
disorder
F 84.4 Overactive disorder associated with mental
retardation and stereotyped movements
F84.5 Asperger's syndrome 299.80 Asperger’s disorder
F84.8 Other pervasive developmental disorders PDDNOS
F84.9 Pervasive developmental disorder, unspecified299.80 PDDNOS
Table 1. Overview of PDD categories in ICD-10 and DSM-IV-TR.
2.2. Epidemiological studies on autism
The first epidemiological study of autistic disorder was published in 1966. Viktor Loter, the au‐
thor, thereby informed the health public that the prevalence of autistic disorder was low,
namely four to five autistic children per 10 000 inhabitants [15]. Epidemiological studies in
1980s and 1990s registered a significant increase in the prevalence of autistic disorder in differ‐
ent parts of the world. Research done in Wales has shown that autism prevalence in respond‐
ents born between 1977 and 1979 was 3.3, while the prevalence in the population born between
1987 and 1989 9.2 [16]. The prevalence of autism in Iceland grew from 4.2 persons in respond‐
ents born between 1974 and 1983 to 13.2 in the population born between 1984 and 1993 [17]. A
stable growth in the prevalence of autism during the 1980s and 1990s was also registered in
California [18]. Having analyzed a sample of some 300 000 respondents born between 1988 and
1996, Honda noted that the incidence of autism grew from an earlier 54 to the present 88 per‐
sons, with the highest oscillation being registered in the 1990s [19]. Fombonne conducted a
meta-analysis of 32 epidemiological studies on autistic disorder carried out between 1966 and
2001. Data was collected on the prevalence of autistic disorder in 13 different countries on a
sample of nearly 5 million people. According to the epidemiological research of the same au‐
thor, 13 in 10 000 liveborn children are born with autism, 3 with Asperger’s syndrome, and 60
with PDDs [20]. Similar data are found in studies of other authors (21,22). According to the
CDC Report, the prevalence rate for autism numbers 6.6 per 1000 [5, 6, 7, 8]. Autism more com‐
monly appears in boys, accounting for the ratio of 4.3:1 in favor of boys [13]. According the co‐
hort study of children in South Thames prevalance of ASD was about 1% [23] while in the past
year a new epidemological study rates closer to 2% [24]. Regarding the prevalence of PDDs in
EU countries, EUGLOREH 2007 stressed the diversity of the definition of autistic disorder and
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methodology yielding and monitoring prevalence, which is confirmed by Table 2. Specially
stressed is the need to approximate the above segments [25].
Area Year Total children inage range Criteria used Age range
Total rate
per 10 000
Aarhus (Denmark) 1972 46 500 Kanner 2-14 4.3
Camberwell (UK) 1979 34 700 Kanner 3-17 4.9
Cambridgeshire (UK) 1999 34 262 DSM-IV 5-11 57
Västerbotten (Sweden) 1983 69 600 Rutter 0-20 5.6
Göteborg1 (Sweden) 1984 128 600 DSM III 4-18 4
Göteborg2 (Sweden) 1986 42 900 DSM III 0-10 7.5
Göteborg3 (Sweden) 1991 40 700 DSM III - R 4-13 11.5
Rhône (France) 1989 103 700 Rutter 5-9 10.8
Iceland 1996 38 746 Rutter 4-12 8.8
Nord-Trondelag (Norwey) 1998 n.a. DSM-IV 3-14 3.8
Northern Finland 1997 152 732 DSM III – R/DSM-IV 5-7 20.7
Ireland East 1997 549 255 DSM III /DSM III - R 0-25 4.94
Table 2. Overview of the prevalence of autistic disorder in EU countries.
The above data leads to the conclusion that the prevalence of autistic disorder in the last 50
years has increased as much as 15 times. Does that mean that the modern world is facing a
kind of an autism epidemic? Despite a series of studies conducted to establish a potential
cause of the same increase, and, by extension, possible etiology of the disorder, [26, 27, 28,
29, 30, 31, 32, 33, 34, 35, 36, 37, 38], many authors continue to believe that the prevalence of
autistic disorder in the 21st century remains as it was 50 years ago [13]. The same authors
argue that this increment is due to more precise diagnostics, changes in diagnostic criteria
and a greater sensitization of the public for the problems of autistic persons. This increase in
the prevalence of autism in the past decades was mostly registered in persons of preserved
intellectual capacity [39], which would argue that the prevalence in persons with typical au‐
tism has remained virtually unchanged.. At this moment it has still not been confirmed or
denied that various factors (pollutants, diet, etc.) have a certain effect on the incidence and
prevalence of autistic disorder but there is clear scientic evidence that no causal relationship
between vaccination and autism [40]. Consequently, no definitive causes of the incurred in‐
crease in the prevalence of the above disorder can still be determined [13].
3. Prevalence of PDDs in Croatia
Croatia monitors data on persons with PDDs within the scope of the Registry. PDDs are
therein separated as a special type of disability and monitored according to the ICD-10 un‐
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der the three-sign category of F84. The onset of a systematic epidemiological monitoring of
data on PDDs goes back to the introduction of the Registry in 2002. The data on the above
disorders is provided by expert evaluation bodies within the education and social welfare
system. These expert evaluation bodies hire experts who are to thank for PDD diagnostics.
The Registry database, as up until 4 May 2012, contains data on 1109 persons with PDDs,
with the largest number of registered under the diagnosis F84.9 (Table 3).
Pervasive developmental disorders categories Number of persons
F 84.0 Childhood autism 267
F84.1 Atypical autism 57
F 84.2 Rett's syndrome 24
F84.3 Other childhood disintegrative disorders 18
F 84.4 Overactive disorder associated with mental
retardation and stereotyped movements
30
F84.5 Asperger's syndrome 44
F84.8 Other pervasive developmental disorders 19
F84.9 Pervasive developmental disorder, unspecified 650
Total 1109
Table 3. View the number of registered people with pervasive developmental disorders in Croatia, according to ICD-10.
The prevalence of PDDs in the overall population of the Republic of Croatia is about 2-3/10 000,
while in children (population aged 0-18) ca. 1/1000, with three times higher incidence in boys.
In Register we see increase (2.6x) number of registrated person with ASD in last seven years
(304 registrated person until 01.01.2005. and 792 after that date). The largest number of persons
with PDDs, namely 759 (70%), belong to the 5–19 age group (Table 4). Primorsko goranska
county and City of Zagreb number the highest prevalence in childhood at just above 1/1000.
Age group
County of residence 0-4 5-9 10-14 15-19 20-29 30-39 40+ Total
m f m f m f m f m f m f m f  
BJELOVARSKO-BILOGORSKA 0 2 4 3 3 2 7 3 2 1 0 0 0 0 27
BRODSKO-POSAVSKA 0 0 10 1 13 4 9 3 4 5 3 1 1 0 54
DUBROVAČKO-NERETVANSKA 2 1 6 0 10 0 0 2 5 3 1 0 0 0 30
GRAD ZAGREB 12 4 48 17 45 11 28 15 33 13 13 5 11 3 258
ISTARSKA 4 0 13 2 13 2 4 5 6 2 5 0 2 1 59
KARLOVAČKA 0 0 7 0 6 1 2 1 4 0 1 0 0 0 22




County of residence 0-4 5-9 10-14 15-19 20-29 30-39 40+ Total
m f m f m f m f m f m f m f  
KOPRIVNIČKO-KRIŽEVAČKA 1 0 7 0 1 0 4 1 3 0 0 0 0 0 17
KRAPINSKO-ZAGORSKA 1 0 4 0 8 2 9 5 6 1 1 0 1 1 39
LIČKO-SENJSKA 1 0 2 0 1 0 1 0 2 0 0 0 0 0 7
MEĐIMURSKA 0 0 10 0 2 3 1 2 2 2 0 0 1 0 23
OSJEČKO-BARANJSKA 1 0 20 3 18 3 6 5 12 6 1 3 2 1 81
POŽEŠKO-SLAVONSKA 0 0 0 0 2 0 1 1 0 1 0 0 0 1 6
PRIMORSKO-GORANSKA 0 2 18 7 24 3 15 4 6 2 2 0 1 0 84
SISAČKO-MOSLAVAČKA 0 0 4 3 8 0 7 1 2 4 1 0 0 0 30
SPLITSKO-DALMATINSKA 7 0 21 4 33 9 18 6 23 8 3 7 8 0 147
ŠIBENSKO-KNINSKA 0 2 5 3 8 1 4 1 7 2 3 1 0 0 37
VARAŽDINSKA 2 0 8 2 6 1 1 6 3 0 0 0 0 29
VIROVITIČKO-PODRAVSKA 1 0 4 1 4 1 1 0 1 2 0 0 0 0 15
VUKOVARSKO-SRIJEMSKA 1 0 10 3 7 1 4 2 5 2 1 0 1 1 38
ZADARSKA 0 0 17 5 7 0 6 3 5 0 3 0 2 0 48
ZAGREBAČKA 0 0 5 2 11 3 8 4 6 5 4 1 1 1 51
Unspecified 0 0 1 0 2 0 0 0 3 0 0 0 1 0 7
TOTAL 33 11 224 56 232 47 136 64 143 62 42 18 32 9 1109
As amended on 5 May 2012
Table 4. Overview of persons with PDDs (F84) by county of residence, sex and age group.
4. Conclusion
All the above leads to the conclusion that there is a difference between the registered prevalen‐
ces of PDDs in Croatia and other countries of the world. According to the last available CDC
data, global prevalence reaches 6.6 per 1000, while in Croatia the rate is ca. 1 in 1000 children
(0-18 age group). This great discrepancy, that is under registration of PDDs, could be ex‐
plained by numerous factors. One of them could be the phenomenon of diagnostic substitution,
which was encountered in the USA before 1990 until which time PDDs, as a diagnosis, could
not secure children the right to special education. In 1990 the passing of the individuals with
Disabilities Education Act was the culmination of a long tradition of state and federal acts pro‐
moting the closing of institutions and encouraging state governments to support families in
their effort to care for and raise their disabled children in their own homes. Autistic children,
especially children with comorbid mental retardation and behavior disorders, who, otherwise,
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would have been institutionalized in the past, consequently, started attending local schools
and were included in the data on school prevalence. Before passing of the above Act, children
were labeled as having mental retardation, learning disabilities, speech or emotional disorders
in order to be granted the right to certain services. The prevalence of autism has, after passing
of the same act, experienced a continual growth. This could partly be ascribed to the method of
funding the education of autistic persons, as well as to granting rights to supplementary serv‐
ices (e.g. whole-year schooling), as defined by the legal amendment. The effects of these factors
on the existing estimations are controversial and illustrative of the reason why the educational
administrative data presented in some media-covered studies may affect the display of the
number of autistic persons [9]. Whether this phenomenon of diagnostic substitution currently
has occurred in Croatia cannot be established with certainty. A proof in favor of its existence
could be the fact that there are a total of 141 persons who have official decisions on special edu‐
cation with autism stated under item Orientation list. On the other hand, according to the same
decision on special education, 6961 pupils/high school students with unspecified disorders in
verbal communication, 3 888 pupils/students with mental retardation (whereof some 65%
have light retardation) and a surprising number of 7 219 with multiple impairments have a
right to special education in regular schools. Some 50% pupils/students who exercise the right
to special education lack the above item of Orientation list so as to escape stigmatization [3].
Each group potentially includes persons with PDDs. A more accurate prevalence of PDDs in
Croatia will be available after following the American example and introducing legal regula‐
tions to separate autism as a special disability category and granting corresponding rights to
persons with PDDs and their families. One should also be reminded of the need of continual
professional training of physicians, special education teachers, psychologists and other profes‐
sionals in new findings in the areas of diagnostics, therapy and rehabilitation of persons with
PDDs. By securing this, the advancement of legislation, diagnostics, IT system and the quality
of diagnosis recording, as well as sensitizing the public to equation of opportunities for per‐
sons with PDDs, will also contribute to advancing the epidemiology of the above disorders.
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